Cibc Private Wealth Group, LLC Abb Vie Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,023,964 shares of ABBV stock, worth $223 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,023,964
Previous 1,054,103
2.86%
Holding current value
$223 Million
Previous $187 Million
14.53%
% of portfolio
0.42%
Previous 0.36%
Shares
36 transactions
Others Institutions Holding ABBV
# of Institutions
4,382Shares Held
1.3BCall Options Held
16.1MPut Options Held
10.9M-
Vanguard Group Inc Valley Forge, PA177MShares$38.7 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$29.7 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$17.4 Billion0.57% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$11.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.09 Billion0.52% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $386B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...